{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T13:37:03Z","timestamp":1782653823107,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0503806"],"award-info":[{"award-number":["2023ZD0503806"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82171302"],"award-info":[{"award-number":["82171302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Capital's Funds for Health Improvement and Research","award":["2024-1-2011"],"award-info":[{"award-number":["2024-1-2011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00415-025-13084-2","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:39:57Z","timestamp":1744209597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Tenecteplase compared to alteplase before mechanical thrombectomy enhances 1-h recanalization and reduces disability in large-vessel occlusion"],"prefix":"10.1007","volume":"272","author":[{"given":"Lu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiao","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6576-0033","authenticated-orcid":false,"given":"Xiuhai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"13084_CR1","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/2396987321989865","volume":"6","author":"E Berge","year":"2021","unstructured":"Berge E, Whiteley W, Audebert H et al (2021) European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J 6:I\u2013LXII. https:\/\/doi.org\/10.1177\/2396987321989865","journal-title":"Eur Stroke J"},{"key":"13084_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/neurintsurg-2021-017441","volume":"14","author":"N Arrarte Terreros","year":"2022","unstructured":"Arrarte Terreros N, Bruggeman AAE, Swijnenburg ISJ et al (2022) Early recanalization in large-vessel occlusion stroke patients transferred for endovascular treatment. J Neurointerv Surg 14:480. https:\/\/doi.org\/10.1136\/neurintsurg-2021-017441","journal-title":"J Neurointerv Surg"},{"key":"13084_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/01.Str.0000258112.14918.24","volume":"38","author":"J-H Rha","year":"2007","unstructured":"Rha J-H, Saver JL (2007) The impact of recanalization on ischemic stroke outcome\u2014a meta-analysis. Stroke 38:967\u2013973. https:\/\/doi.org\/10.1161\/01.Str.0000258112.14918.24","journal-title":"Stroke"},{"key":"13084_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/strokeaha.117.019261","volume":"49","author":"G Tsivgoulis","year":"2018","unstructured":"Tsivgoulis G, Katsanos AH, Schellinger PD et al (2018) Successful reperfusion with intravenous thrombolysis preceding mechanical thrombectomy in large-vessel occlusions. Stroke 49:232. https:\/\/doi.org\/10.1161\/strokeaha.117.019261","journal-title":"Stroke"},{"key":"13084_CR5","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMoa2107727","volume":"385","author":"NE Lecouffe","year":"2021","unstructured":"Lecouffe NE, Kappelhof M, Treurniet KM et al (2021) A randomized trial of intravenous alteplase before endovascular treatment for stroke. N Engl J Med 385:1833\u20131844. https:\/\/doi.org\/10.1056\/NEJMoa2107727","journal-title":"N Engl J Med"},{"key":"13084_CR6","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMoa2001123","volume":"382","author":"P Yang","year":"2020","unstructured":"Yang P, Zhang Y, Zhang L et al (2020) Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med 382:1981\u20131993. https:\/\/doi.org\/10.1056\/NEJMoa2001123","journal-title":"N Engl J Med"},{"key":"13084_CR7","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/NEJMoa1716405","volume":"378","author":"BCV Campbell","year":"2018","unstructured":"Campbell BCV, Mitchell PJ, Churilov L et al (2018) Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med 378:1573\u20131582. https:\/\/doi.org\/10.1056\/NEJMoa1716405","journal-title":"N Engl J Med"},{"key":"13084_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.2018.12498","volume":"320","author":"BK Menon","year":"2018","unstructured":"Menon BK, Al-Ajlan FS, Najm M et al (2018) Association of Clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke. J Am Med Assoc 320:1017\u20131026. https:\/\/doi.org\/10.1001\/jama.2018.12498","journal-title":"J Am Med Assoc"},{"key":"13084_CR9","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1161\/strokeaha.118.022335","volume":"49","author":"P Seners","year":"2018","unstructured":"Seners P, Turc G, Naggara O et al (2018) Post-thrombolysis recanalization in stroke referrals for thrombectomy incidence, predictors, and prediction scores. Stroke 49:2975\u20132982. https:\/\/doi.org\/10.1161\/strokeaha.118.022335","journal-title":"Stroke"},{"key":"13084_CR10","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1161\/strokeaha.121.037061","volume":"53","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Zhang L, Ospel J et al (2022) Association of intravenous alteplase, early reperfusion, and clinical outcome in patients with large vessel occlusion stroke: most hoc analysis of the randomized DIRECT-MT trial. Stroke 53:1828\u20131836. https:\/\/doi.org\/10.1161\/strokeaha.121.037061","journal-title":"Stroke"},{"key":"13084_CR11","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2165\/00003088-200241150-00001","volume":"41","author":"P Tanswell","year":"2002","unstructured":"Tanswell P, Modi N, Combs D et al (2002) Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Clin Pharmacokinet 41:1229\u20131245. https:\/\/doi.org\/10.2165\/00003088-200241150-00001","journal-title":"Clin Pharmacokinet"},{"key":"13084_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1517\/17425255.2012.652615","volume":"8","author":"P Acheampong","year":"2012","unstructured":"Acheampong P, Ford GA (2012) Pharmacokinetics of alteplase in the treatment of ischaemic stroke. Expert Opin Drug Metab Toxicol 8:271\u2013281. https:\/\/doi.org\/10.1517\/17425255.2012.652615","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"13084_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5853\/jos.2018.01998","volume":"21","author":"P Seners","year":"2019","unstructured":"Seners P, Caroff J, Chausson N et al (2019) Recanalization before thrombectomy in tenecteplase vs alteplase-treated drip-and-ship patients. J Stroke 21:105\u2013107. https:\/\/doi.org\/10.5853\/jos.2018.01998","journal-title":"J Stroke"},{"key":"13084_CR14","doi-asserted-by":"publisher","first-page":"E2173","DOI":"10.1212\/wnl.0000000000012915","volume":"97","author":"G Gerschenfeld","year":"2021","unstructured":"Gerschenfeld G, Smadja D, Turc G et al (2021) Functional outcome, recanalization, and hemorrhage rates after large vessel occlusion stroke treated with tenecteplase before thrombectomy. Neurology 97:E2173\u2013E2184. https:\/\/doi.org\/10.1212\/wnl.0000000000012915","journal-title":"Neurology"},{"key":"13084_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3174\/ajnr.A1408","volume":"30","author":"IYL Tan","year":"2009","unstructured":"Tan IYL, Demchuk AM, Hopyan J et al (2009) CT Angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. Am J Neuroradiol 30:525\u2013531. https:\/\/doi.org\/10.3174\/ajnr.A1408","journal-title":"Am J Neuroradiol"},{"key":"13084_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/s0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke W, Kaste M, Fieschi C et al (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352:1245\u20131251. https:\/\/doi.org\/10.1016\/s0140-6736(98)08020-9","journal-title":"Lancet"},{"key":"13084_CR17","doi-asserted-by":"publisher","first-page":"E102","DOI":"10.1161\/STR.0b013e318262de57","volume":"43","author":"M Mazya","year":"2012","unstructured":"Mazya M (2012) Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe implementation of treatments in stroke (SITS) symptomatic intracerebral hemorrhage risk score (vol 43, pg 1524, 2012). Stroke 43:E102\u2013E102. https:\/\/doi.org\/10.1161\/STR.0b013e318262de57","journal-title":"Stroke"},{"key":"13084_CR18","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1161\/strokeaha.123.042691","volume":"54","author":"T Checkouri","year":"2023","unstructured":"Checkouri T, Gerschenfeld G, Seners P et al (2023) Early recanalization among patients undergoing bridging therapy with tenecteplase or alteplase. Stroke 54:2491\u20132499. https:\/\/doi.org\/10.1161\/strokeaha.123.042691","journal-title":"Stroke"},{"key":"13084_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0140-6736(22)01054-6","volume":"400","author":"BK Menon","year":"2022","unstructured":"Menon BK, Buck BH, Singh N et al (2022) Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet 400:161\u2013169","journal-title":"Lancet"},{"key":"13084_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jcph.2164","volume":"63","author":"F Tang","year":"2023","unstructured":"Tang F, Langenhorst J, Dang S et al (2023) Population pharmacokinetics of tenecteplase in patients with acute myocardial infarction and application to patients with acute ischemic stroke. J Clin Pharmacol 63:197\u2013209. https:\/\/doi.org\/10.1002\/jcph.2164","journal-title":"J Clin Pharmacol"},{"key":"13084_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jemermed.2023.03.059","volume":"64","author":"Y Kobayashi","year":"2023","unstructured":"Kobayashi Y, Saito T, Kawabata Y et al (2023) A 5-minute delay from bolus injection to infusion halves plasma concentration of tissue plasminogen activator. J Emerg Med 64:709\u2013713. https:\/\/doi.org\/10.1016\/j.jemermed.2023.03.059","journal-title":"J Emerg Med"},{"key":"13084_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1747-4949.2012.00924.x","volume":"9","author":"C Smith","year":"2014","unstructured":"Smith C, Al-Nuaimi Y, Wainwright J et al (2014) The influence of bolus to infusion delays on plasma tissue plasminogen activator levels. Int J Stroke 9:939\u2013942. https:\/\/doi.org\/10.1111\/j.1747-4949.2012.00924.x","journal-title":"Int J Stroke"},{"key":"13084_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1023\/a:1011952602122","volume":"11","author":"K Huber","year":"2001","unstructured":"Huber K (2001) Plasminogen activator inhibitor type-1 (part two): role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents. J Thromb Thrombolysis 11:195\u2013202. https:\/\/doi.org\/10.1023\/a:1011952602122","journal-title":"J Thromb Thrombolysis"},{"key":"13084_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/s0140-6736(22)02600-9","volume":"401","author":"YJ Wang","year":"2023","unstructured":"Wang YJ, Li SY, Pan YS et al (2023) Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferioritytrial. Lancet 401:645\u2013654. https:\/\/doi.org\/10.1016\/s0140-6736(22)02600-9","journal-title":"Lancet"},{"key":"13084_CR25","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/strokeaha.122.041061","volume":"54","author":"V Yogendrakumar","year":"2023","unstructured":"Yogendrakumar V, Churilov L, Guha P et al (2023) Tenecteplase treatment and thrombus characteristics associated with early reperfusion: an EXTEND-IA TNK trials analysis. Stroke 54:706\u2013714. https:\/\/doi.org\/10.1161\/strokeaha.122.041061","journal-title":"Stroke"},{"key":"13084_CR26","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa1109842","volume":"366","author":"M Parsons","year":"2012","unstructured":"Parsons M, Spratt N, Bivard A et al (2012) A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med 366:1099\u20131107. https:\/\/doi.org\/10.1056\/NEJMoa1109842","journal-title":"N Engl J Med"},{"key":"13084_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100406","author":"Q Ye","year":"2022","unstructured":"Ye Q, Zhai F, Chao B et al (2022) Rates of intravenous thrombolysis and endovascular therapy for acute ischaemic stroke in China between 2019 and 2020. Lancet Region Health-Western Pacific. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100406","journal-title":"Lancet Region Health-Western Pacific"},{"key":"13084_CR28","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1212\/wnl.0000000000003981","volume":"88","author":"A Meretoja","year":"2017","unstructured":"Meretoja A, Keshtkaran M, Tatlisumak T et al (2017) Endovascular therapy for ischemic stroke save a minute-save a week. Neurology 88:2123\u20132127. https:\/\/doi.org\/10.1212\/wnl.0000000000003981","journal-title":"Neurology"},{"key":"13084_CR29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/strokeaha.113.002910","volume":"45","author":"A Meretoja","year":"2014","unstructured":"Meretoja A, Keshtkaran M, Saver JL et al (2014) Stroke thrombolysis save a minute, save a day. Stroke 45:1053\u20131058. https:\/\/doi.org\/10.1161\/strokeaha.113.002910","journal-title":"Stroke"},{"key":"13084_CR30","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1212\/WNL.0b013e3182a4a4d2","volume":"81","author":"A Meretoja","year":"2013","unstructured":"Meretoja A, Weir L, Ugalde M et al (2013) Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology 81:1071\u20131076. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a4a4d2","journal-title":"Neurology"},{"key":"13084_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/circoutcomes.116.003242","author":"N Kamal","year":"2017","unstructured":"Kamal N, Holodinsky JK, Stephenson C et al (2017) Improving door-to-needle times for acute ischemic stroke: effect of rapid patient registration, moving directly to computed tomography, and giving alteplase at the computed tomography scanner. Circ Cardiovasc Qual Outcomes. https:\/\/doi.org\/10.1161\/circoutcomes.116.003242","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"13084_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/s1474-4422(24)00206-0","volume":"23","author":"MW Parsons","year":"2024","unstructured":"Parsons MW, Yogendrakumar V, Churilov L et al (2024) Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4<middle dot>5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial. Lancet Neurol 23:775\u2013786. https:\/\/doi.org\/10.1016\/s1474-4422(24)00206-0","journal-title":"Lancet Neurol"},{"key":"13084_CR33","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1001\/jama.2024.14721","volume":"332","author":"X Meng","year":"2024","unstructured":"Meng X, Li S, Dai H et al (2024) Tenecteplase vs alteplase for patients with acute ischemic stroke. J Am Med Assoc 332:1437\u20131445. https:\/\/doi.org\/10.1001\/jama.2024.14721","journal-title":"J Am Med Assoc"},{"key":"13084_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107931","author":"RR Karamchandani","year":"2024","unstructured":"Karamchandani RR, Asimos AW, Strong D et al (2024) Early recanalization after tenecteplase versus alteplase: experience in a large stroke network. J Stroke Cerebrovasc Dis. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2024.107931","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"13084_CR35","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1007\/s00415-024-12530-x","volume":"271","author":"P Hendrix","year":"2024","unstructured":"Hendrix P, Gross BA, Allahdadian S et al (2024) Tenecteplase versus alteplase before stroke thrombectomy: outcomes after system-wide transitions in Pennsylvania. J Neurol 271:5637\u20135641. https:\/\/doi.org\/10.1007\/s00415-024-12530-x","journal-title":"J Neurol"},{"key":"13084_CR36","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000209398","author":"G Gerschenfeld","year":"2024","unstructured":"Gerschenfeld G, Turc G, Obadia M et al (2024) Functional outcome and hemorrhage rates after bridging therapy with tenecteplase or alteplase in patients with large ischemic core. Neurology. https:\/\/doi.org\/10.1212\/wnl.0000000000209398","journal-title":"Neurology"},{"key":"13084_CR37","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/strokeaha.115.011721","volume":"47","author":"M Ribo","year":"2016","unstructured":"Ribo M, Molina CA, Cobo E et al (2016) Association between time to reperfusion and outcome is primarily driven by the time from imaging to reperfusion. Stroke 47:999\u20131004. https:\/\/doi.org\/10.1161\/strokeaha.115.011721","journal-title":"Stroke"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13084-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13084-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13084-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T12:41:51Z","timestamp":1747658511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13084-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["13084"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13084-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"15 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study adhered to the principles of the Declaration of Helsinki and was conducted with approval from Xuanwu Hospital, Capital Medical University ethics committee (Approval Number: [2021] 215, Approval Date: October 20th, 2021). Informed consent for data collection was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"324"}}